Met Life Investment Management, LLC Durect Corp Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.9 - $1.31 $77,559 - $112,891	-86,177 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$1.21 - $1.61 $74,592 - $99,251	61,647 Added 251.31%	86,177 $110,000
Q3 2021 Jun 21, 2023	BUY	$1.21 - $1.61 $104,274 - $138,744	86,177 New	86,177 $110,000
Q3 2021 Mar 22, 2023	BUY	$1.21 - $1.61 $74,592 - $99,251	61,647 Added 251.31%	86,177 $110,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $74,592 - $99,251	61,647 Added 251.31%	86,177 $110,000
Q2 2021 May 17, 2024	SELL	$1.6 - $2.02 $111,790 - $141,135	-69,869 Reduced 74.01%	24,530 $39,000
Q2 2021 Jun 21, 2023	BUY	$1.6 - $2.02 $39,248 - $49,550	24,530 New	24,530 $39,000
Q2 2021 Mar 22, 2023	SELL	$1.6 - $2.02 $111,790 - $141,135	-69,869 Reduced 74.01%	24,530 $39,000
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $111,790 - $141,135	-69,869 Reduced 74.01%	24,530 $40,000
Q1 2021 May 17, 2024	BUY	$1.86 - $2.87 $175,582 - $270,925	94,399 New	94,399 $186,000
Q1 2021 Jun 26, 2023	BUY	$1.86 - $2.87 $175,582 - $270,925	94,399 New	94,399 $187 Million
Q1 2021 Mar 22, 2023	BUY	$1.86 - $2.87 $83,486 - $128,819	44,885 Added 90.65%	94,399 $186,000
Q1 2021 May 14, 2021	BUY	$1.86 - $2.87 $83,486 - $128,819	44,885 Added 90.65%	94,399 $187,000
Q4 2020 May 24, 2024	BUY	$1.65 - $2.43 $11,337 - $16,696	6,871 Added 16.11%	49,514 $102,000
Q4 2020 Jun 22, 2023	BUY	$1.65 - $2.43 $81,698 - $120,319	49,514 New	49,514 $102,000
Q4 2020 Mar 22, 2023	BUY	$1.65 - $2.43 $11,337 - $16,696	6,871 Added 16.11%	49,514 $102,000
Q4 2020 Feb 16, 2021	BUY	$1.65 - $2.43 $11,337 - $16,696	6,871 Added 16.11%	49,514 $102,000
Q3 2020 May 24, 2024	SELL	$1.6 - $2.35 $80,131 - $117,692	-50,082 Reduced 54.01%	42,643 $72.9 Million
Q3 2020 Jun 26, 2023	BUY	$1.6 - $2.35 $68,228 - $100,211	42,643 New	42,643 $72,000
Q3 2020 Mar 22, 2023	SELL	$1.6 - $2.35 $80,131 - $117,692	-50,082 Reduced 54.01%	42,643 $72,000
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $80,131 - $117,692	-50,082 Reduced 54.01%	42,643 $73,000
Q2 2020 May 24, 2024	BUY	$1.33 - $2.76 $123,324 - $255,920	92,725 New	92,725 $215 Million
Q2 2020 Jun 26, 2023	BUY	$1.33 - $2.76 $123,324 - $255,920	92,725 New	92,725 $215,000
Q2 2020 Mar 22, 2023	BUY	$1.33 - $2.76 $123,324 - $255,920	92,725 New	92,725 $215,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $123,324 - $255,920	92,725 New	92,725 $215,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $78,307 - $124,848	-73,875 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $67,226 - $165,480	73,875 New	73,875 $158,000

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $175M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account